Analysis of BRAF and NRAS mutation status in advanced melanoma patients treated with anti-CTLA-4 antibodies: Association with overall survival?

Joanna Mangana, Phil F. Cheng, Katja Schindler, Benjamin Weide, Ulrike Held, Anna L. Frauchiger, Emanuella Romano, Katharina C. Kähler, Sima Rozati, Markus Rechsteiner, Holger Moch, Olivier Michielin, Claus Garbe, Axel Hauschild, Christoph Hoeller, Reinhard Dummer, Simone M. Goldinger

Research output: Contribution to journalArticlepeer-review

19 Scopus citations

Fingerprint

Dive into the research topics of 'Analysis of BRAF and NRAS mutation status in advanced melanoma patients treated with anti-CTLA-4 antibodies: Association with overall survival?'. Together they form a unique fingerprint.

Medicine & Life Sciences